Qualification:
July 2010
Full-time resident Student. Training in Internal Medicine with particular regard for metabolic diseases, namely dylipidemias, atherosclerosis, and prevention of cardiovascular diseases. Training in Transfusion Medicine, and extracorporeal therapeutic techniques, such as therapeutic plasmapheresis, and particularly Lipid apheresis and LDL-apheresis. Clinical ward and outpatient activities.
July 2011
Graduated in Medicine and Surgery at the Department of Internal Medicine and Medical Specialties of the University “La Sapienza” of Rome (full mark: 110/110 cum laude), with an experimental dissertation. Supervisor: Professor Claudia Stefanutti. Working on genetically determined dyslipidemias, diagnosis and pharmacological and non-pharmacological treatment. Extracorporeal Therapeutic Techniques Unit- Immunohematology and Transfusion Medicine “La Sapienza” University of Rome – “Umberto I” Hospital, Rome. Resarch fellow in Clinical Trials devoted to the treatment of inherited metabolic diseases.
March 2012
Completed the online training programme entitled “Essential Good Clinical Practice” by Brookwood International Academy and passed the online examination. Date of examination: 27 march 2012, certificate number: SA2235/MIPO3801011 MultiNational.
ClinTrak EDC Training Certificate (Online data uploading system for clinical trials)
Participation in the research project (Clinical Trial) MODE Study (CERENIS Therapeutics Inc., USA) with the role of subinvestigator.
July 2012
Resident physician enrolled in the Clinic Pathology residency program at the “Sapienza” University in Rome, Italy.
2012-2014
Participation in the research project (Clinical Trial) PASCAL Study (Kowa Pharmaceuticals America, Inc. ) with the role of co-investigator.
2013-2014
Participation in the research project (Clinical Trial) ODYSSEY (Sanofi and Regeneron Pharmaceuticals, Inc. with the role of subinvestigator.
2013-2014
Participation in the research project (Clinical Trial) Mipomersen (Genzyme-Sanofi Company) with the role of subinvestigator.
List of publications:
1 Stefanutti C, Morozzi C, Petta A. Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia. Cytokine. 2011 Dec;56(3):842-9.
2 Stefanutti C, Vivenzio A, Ferraro PM, Morozzi C, Belotherkovsky D. Apheresis-inducible cytokine pattern change in severe, genetic dyslipidemias. Cytokine. 2011 Dec;56(3):835-41.
3 Stefanutti C, Di Giacomo S, Morozzi C. LDL apheresis: an update and overview. LDL apheresis in Sardinia, Italy (SMILDLa). G Ital Nefrol. 2012 Jan-Feb;29 Suppl 54:S14-8. Italian.
4 Stefanutti C, Morozzi C, Di Giacomo S. LDL-aferesi: stato dell’arte. Giornale Italiano dell’Arteriosclerosi, 2011; Anno 3, N.1/2012 p 43-71.
5 Stefanutti C and Morozzi C. Low density lipoprotein apheresis.
Chapter ID: _8305_Chapter Title: Low Density Lipoprotein apheresis
Book ID: _921_Book Title: Hemodialysis, When, How, Why.
6 Stefanutti C, Morozzi C, Di Giacomo S. New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia. Curr Med Chem. 2012 Oct 1;19(28):4861-8.
7 Bosi S, Barbieri A, Baldelli M, Censi S, Naldi M, Squeri A, Morozzi C, Stefanutti C. How new imaging techniques can aid in defining the cardiovascular profile of the high-risk patient. G Chir. 2012 Nov;33(11-12):429-34.
8 Stefanutti C, Morozzi C, Perrone G, Di Giacomo S, Vivenzio A, D’Alessandri G. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating. G Chir. 2012 Nov;33(11-12):444-9.
9 G. Perrone, R. Brunelli, C. Morozzi, C. Stefanutti. La prevenzione ed il trattamento dei fattori di rischio per la malattia cardiovascolare nella donna in pre e postmenopausa: linee guida a confronto. Giorn. It. Ost. Gin. 2012, Vol. XXXIV – n. 5.
10 C. Stefanutti, G. Perrone, O. Capri, C. Morozzi. Lipidoaferesi ed LDL-aferesi in gravidanza. Giorn. It. Ost. Gin. 2012, Vol. XXXIV – n. 5.
11 C. Stefanutti, C. Morozzi, G. Perrone, P. Galoppi, F.R. Patacchioli. Differenze sessuali nel metabolismo dei lipidi e delle lipoproteine plasmatiche. Giorn. It. Ost. Gin. 2012, Vol. XXXIV – n. 5
12 Claudia Stefanutti, Maria Gozzer, Livia Pisciotta, Patrizia D’Eufemia, Giovanna Bosco, Claudia Morozzi, Francesco Papadia, Manhaz Shafii, Serafina Di Giacomo, Stefano Bertolini. A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. Atherosclerosis Suppl. 2013.
13 Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemia-related acute pancreatitis. Ther Apher Dial. 2013 Apr;17(2):130-7.
14 Stefanutti C, Morozzi C, ^ and the Italian Multicenter Study on Low-Density-Lipoprotein -Apheresis Working Group, The Italian Multicenter Study on Low-Density-Lipoprotein -Apheresis Working Group: 2009 survey. Ther Apher Dial. 2013.
15 Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemia-related acute pancreatitis: myth or reality?. Ther Apher Dial. 2013 Aug;17(4):464-5.
Abstract:
1 Stefanutti C, Shafii M, Di Giacomo S, Morozzi C, Mazzilli S and the Italian Multicenter Study on Low-Density-Lipoprotein-Apheresis Working Group: H.E.L.P. LDL-apheresis clinical experience in Italy. Ther Apher Dial. 2011; 15(4) A24:69.
2 Stefanutti Claudia, Morozzi Claudia, Di Giacomo Serafina. Effects of LDL-apheresis on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia. Ther Apher Dial. Nov 11, 2011-11-28.
3 Pisciotta L, Stefanutti C, Gozzer M, Morozzi C, Bosco G, D’Eufemia P, Papadia F, Bertolini S. A three month-old baby with severe hyperchilomicronaemia: molecular diagnosis and treatment. Giornale italiano dell’arteriosclerosi – Anno 2 • N.3/2011 p 86.
4 Stefanutti C, Di Giacomo S, Morozzi C. New evidences of D.A.LI. LDL-apheresis effects on circulating pro- and anti-inflammatory cytokines.Ther Apher Dial. 2011; 15(4) A23-A24:68.
5 Stefanutti C, Mazza F, Di Giacomo S, Morozzi C. Il trattamento combinato con Dif1Stat® e dieta riduce i livelli plasmatici dei lipidi nella moderata ipercolesterolemia con maggiore efficacia rispetto al trattamento con sola dieta: studio randomizzato per gruppi paralleli. Giornale Italiano dell’Arteriosclerosi, 2011; Anno 3, N.1/2012 p 75-76.